- Home
- YORW vs BNTC Comparison
YORW vs BNTC Comparison
Compare YORW & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- BNTC
- Stock Information
- Founded
- YORW 1816
- BNTC 1995
- Country
- YORW United States
- BNTC United States
- Employees
- YORW N/A
- BNTC N/A
- Industry
- YORW Water Supply
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- BNTC Health Care
- Exchange
- YORW Nasdaq
- BNTC Nasdaq
- Market Cap
- YORW 433.6M
- BNTC 365.1M
- IPO Year
- YORW N/A
- BNTC N/A
- Fundamental
- Price
- YORW $32.36
- BNTC $15.70
- Analyst Decision
- YORW
- BNTC Strong Buy
- Analyst Count
- YORW 0
- BNTC 5
- Target Price
- YORW N/A
- BNTC $24.80
- AVG Volume (30 Days)
- YORW 88.1K
- BNTC 63.3K
- Earning Date
- YORW 11-05-2025
- BNTC 11-13-2025
- Dividend Yield
- YORW 2.74%
- BNTC N/A
- EPS Growth
- YORW N/A
- BNTC N/A
- EPS
- YORW 1.37
- BNTC N/A
- Revenue
- YORW $76,236,000.00
- BNTC N/A
- Revenue This Year
- YORW $7.50
- BNTC N/A
- Revenue Next Year
- YORW $6.33
- BNTC N/A
- P/E Ratio
- YORW $23.82
- BNTC N/A
- Revenue Growth
- YORW 4.09
- BNTC N/A
- 52 Week Low
- YORW $29.68
- BNTC $9.10
- 52 Week High
- YORW $38.50
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- YORW 61.60
- BNTC 59.01
- Support Level
- YORW $31.59
- BNTC $15.18
- Resistance Level
- YORW $32.79
- BNTC $16.24
- Average True Range (ATR)
- YORW 0.66
- BNTC 0.79
- MACD
- YORW 0.16
- BNTC 0.07
- Stochastic Oscillator
- YORW 82.87
- BNTC 66.10
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.